Celldex Therapeutics, Inc. (CLDX)

Celldex Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	23.04	28.36	34.81	29.43	39.14	43.84
Short-Term Investments	607.29	696.93	388.78	275.52	369.11	150.59
Cash & Short-Term Investments	630.34	725.28	423.6	304.95	408.25	194.42
Cash Growth	-21.44%	71.22%	38.91%	-25.30%	109.98%	201.98%
Accounts Receivable	0.09	0.7	2.63	0.35	0.17	1.8
Other Current Assets	17.98	21.18	5.47	12.39	2.42	1.62
Total Current Assets	648.4	747.16	431.69	317.69	410.84	197.84
Net Property, Plant & Equipment	7.51	8.24	6.64	7.75	6.52	7.26
Other Intangible Assets	27.19	27.19	27.19	27.19	27.19	30.69
Other Long-Term Assets	9.3	9.75	0.11	0.1	0.1	0.04
Total Assets	692.41	792.34	465.63	352.74	444.65	235.84
Accounts Payable	2.07	3.27	3.49	3.34	1.23	1.05
Accrued Expenses	28.42	33.84	22.03	12.84	12	8.46
Current Portion of Leases	1.54	1.45	1.61	1.45	1.75	1.33
Other Current Liabilities	0.93	0.94	-	-	-	-
Total Current Liabilities	32.96	39.5	31.13	18.61	16.53	14.21
Long-Term Leases	1.5	2.36	0.93	2.59	1.3	2.15
Other Long-Term Liabilities	2.54	3.47	4.4	5.33	7.35	10.12
Total Long-Term Liabilities	4.04	5.83	5.33	7.92	8.65	12.28
Total Liabilities	37	45.34	36.46	26.53	25.18	26.48
Common Stock	0.07	0.07	0.06	0.05	0.05	0.04
Additional Paid-in Capital	2,318	2,299	1,823	1,581	1,561	1,280
Accumulated Other Comprehensive Income	3.34	3.31	3.31	1.26	1.89	2.59
Retained Earnings	-1,666	-1,555	-1,397	-1,256	-1,144	-1,073
Shareholders' Equity	655.41	747.01	429.17	326.2	419.48	209.36
Total Liabilities & Equity	692.41	792.34	465.63	352.74	444.65	235.84
Total Debt	3.03	3.81	2.54	4.03	3.04	3.48
Net Cash (Debt)	627.31	721.47	421.06	300.92	405.21	190.94
Net Cash Growth	-13.05%	71.35%	39.92%	-25.74%	112.22%	214.43%
Net Cash Per Share	9.45	11.20	8.69	6.42	9.45	6.44
Book Value	655.41	747.01	429.17	326.2	419.48	209.36
Book Value Per Share	9.88	11.60	8.86	6.96	9.78	7.06
Tangible Book Value	628.22	719.82	401.98	299.01	392.29	178.67
Tangible Book Value Per Share	9.47	11.18	8.30	6.38	9.15	6.03

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q